Pharmacist Diabetes | Ophthamology | Weight Management Podcast 30m

GLP-1 receptor agonists have revolutionized the treatment of diabetes and obesity, but recent data suggest a potential link to a higher risk of various ocular disorders, especially with long-term use. This episode reviews the findings of these studies, places them in context with the overall benefits of GLP-1s, and covers what pharmacists should know when counseling patients. Listen in to enhance your ability to guide safe, informed medication choices and stay updated on emerging safety information. 

Learning Objectives

Upon successful completion of this course, pharmacists should be able to:
1. Describe the potential relationship between GLP-1 receptor agonist use and the development of ocular disorders.
2. Identify key considerations for pharmacist counseling related to GLP-1 therapy and ocular health.

Faculty

Joshua Davis Kinsey, PharmD

VP, Education
CEimpact

Disclosures:

Joshua Davis Kinsey has no relevant financial relationships with ineligible companies to disclose.

Jamie Pitlick, PharmD, BCPS, BC-ADM

Professor and Chair of Pharmacy Practice
Drake University College of Pharmacy and Health Sciences

Disclosures:

Jamie Pitlick has no relevant financial relationships with ineligible companies to disclose.

Course Details